People | December 22, 2022
BeatO appoints Dr. Navneet Agrawal as Chief Clinical Officer
He has published more than 100 research papers in several prestigious national and international journals
He has published more than 100 research papers in several prestigious national and international journals
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
She joins Enveda from Gilead Sciences
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Subscribe To Our Newsletter & Stay Updated
